found: Washington post WWW site, viewed June 12, 2017(Angela Brodie, an English-born scientist whose seminal research into a compound that blocks estrogen production helped generate a new class of drugs to treat breast cancer and was credited with saving thousands of lives, died June 7 [2017] at her home in Fulton, Md.; she was 82; the University of Maryland School of Medicine, where she was a professor emeritus of pharmacology and experimental therapeutics, announced the death; Dr. Brodie's formative years as a researcher were spent at the Worcester Foundation for Experimental Biology in Shrewsbury, Mass.; in 1979, her husband Harry Brodie left [Worcester Foundation] for an administrative post at the National Institutes of Health, while Angela Brodie joined U-Md.; Angela Mary Hartley was born in Oldham, near Manchester, England, on Sept. 28, 1934; received a doctorate in 1961 from the University of Manchester in chemical pathology; retired from U.-Md. in 2016; spent the final years of her career conducting research with a colleague, Vincent C.O. Njar, into the use of aromatase inhibitors to treat prostate cancer)